The defensive nature of healthcare stocks has made them more attractive in this unsettled market.
Jim Cramer is urging investors to sell pharmaceutical stocks calling the sector “just one expensive graveyard.”
The penny dividend increase will push the current yield of BMY shares to 5.0%.
Gilead Sciences is a cash flow machine, but the stock has never paid a quarterly dividend.
Global pharmaceutical company Bristol-Myers Squibb announced late yesterday that its Board of Directors has approved a quarterly dividend of $.31 per share.